본문 바로가기
KERD
논문KCI 등재

Biomarkers Predicting Treatment-Response in Nephrotic Syndrome of Children: A Systematic Review

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류소아과학

초록

Purpose: Nephrotic syndrome (NS) is the most common form of glomerulopathy in children. Most pediatric patients respond to glucocorticosteroid treatment (steroid- sensitive NS, SSNS), while approximately 10–15% will remain unresponsive or later become steroid-resistant. There has been a long-standing effort to find biomarkers that may predict steroid responsiveness. Methods: We systematically reviewed current studies which investigated clinically relevant biomarkers for predicting steroid responsiveness in pediatric NS. We performed a PubMed and EMBASE search to identify eligible articles. We collected data on urinary markers, blood/serum markers (including cellular phenotypes and mRNA expression), genotypes and HLA allele frequency. Results: A total of 659 articles were identified following electronic and manual searches. After reviewing the titles, abstracts, and full texts, 72 eligible articles were finally included. Vitamin D-binding protein (VDBP) seemed to be significantly elevated in SRNS than in SSNS, in both serum and urine specimen, although further validation is required. Conclusions: The present paper narratively illustrates current understandings of potential biomarkers that may help predict steroid responsiveness. Further investigation and collaboration involving a larger number of patients are necessary.

Abstract

Purpose: Nephrotic syndrome (NS) is the most common form of glomerulopathy in children. Most pediatric patients respond to glucocorticosteroid treatment (steroid- sensitive NS, SSNS), while approximately 10–15% will remain unresponsive or later become steroid-resistant. There has been a long-standing effort to find biomarkers that may predict steroid responsiveness. Methods: We systematically reviewed current studies which investigated clinically relevant biomarkers for predicting steroid responsiveness in pediatric NS. We performed a PubMed and EMBASE search to identify eligible articles. We collected data on urinary markers, blood/serum markers (including cellular phenotypes and mRNA expression), genotypes and HLA allele frequency. Results: A total of 659 articles were identified following electronic and manual searches. After reviewing the titles, abstracts, and full texts, 72 eligible articles were finally included. Vitamin D-binding protein (VDBP) seemed to be significantly elevated in SRNS than in SSNS, in both serum and urine specimen, although further validation is required. Conclusions: The present paper narratively illustrates current understandings of potential biomarkers that may help predict steroid responsiveness. Further investigation and collaboration involving a larger number of patients are necessary.

참고문헌 (144)

  1. Dossier C, "Epidemiology of idiopathic nephrotic syndrome in children:endemic or epidemic?", Pediatr Nephrol, 31, pp.2299~2308 (2016)
  2. Noone DG, "Idiopathic nephrotic syndrome in children", The Lancet, 392, pp.61~74 (2018)
  3. Tullus K, "Management of steroid-resistant nephrotic syndrome in children and adolescents", The Lancet Child and Adolescent Health, 2, pp.880~890 (2018)
  4. Lombel RM, "Treatment of steroid-sensitive nephrotic syndrome : New guidelines from KDIGO", Pediatric Nephrology, 28, pp.415~426 (2013)
  5. Canetta PA, "The Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic Syndrome", Front Pediatr, 3, pp.78~ (2015)
  6. Stone H, "The Search for biomarkers to aid in diagnosis, differentiation, and prognosis of childhood idiopathic nephrotic syndrome", Frontiers in Pediatrics, 7 (2019)
  7. Trautmann A, "IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome", Pediatric Nephrology, 35, pp.1529~1561 (2020)
  8. Saleem MA, "Molecular stratification of idiopathic nephrotic syndrome", Nat Rev Nephrol, 15, pp.750~765 (2019)
  9. Trautmann A, "Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children", J Am Soc Nephrol, 28, pp.3055~3065 (2017)
  10. Lee JM, "Current understandings in treating children with steroid-resistant nephrotic syndrome", Pediatr Nephrol, 36, pp.747~761 (2021)
  11. Trautmann A, "Risk factors for posttransplant recurrence of steroid resistant nephrotic syndrome(SRNS) : Results from the podonet registry", Pediatric Nephrology, 30, pp.1557~1558 (2015)
  12. Kang HG, "Recurrence and Treatment after Renal Transplantation in Children with FSGS", Biomed Res Int, 2016, pp.6832971~ (2016)
  13. Allen PJ, "Recurrent glomerulonephritis after kidney transplantation : risk factors and allograft outcomes", Kidney Int, 92, pp.461~469 (2017)
  14. Toshiyuki O, "Effect of pre-and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children", Transplantation, 71, pp.628~633 (2001)
  15. McCarthy ET, "Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis", Clin J Am Soc Nephrol, 5, pp.2115~2121 (2010)
  16. Kopp JB, "Podocytopathies", Nat Rev Dis Primers, 6, pp.68~ (2020)
  17. Bensimhon AR, "Treatment of steroid-resistant nephrotic syndrome in the genomic era", Pediatric Nephrology, 34, pp.2279~2293 (2019)
  18. Barnett HL, "The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the international study of kidney disease in children", Journal of Pediatrics, 98, pp.561~564 (1981)
  19. Abdelsalam SM, "Prediction of steroid response in nephrotic syndrome by humoral immunity assessment", Journal of Clinical Immunology, 32, pp.S270~ (2012)
  20. Asokan K, "The role of shear wave elastography in predicting the clinical outcome in paediatric patients with nephrotic syndrome", Pediatric Radiology, 49, pp.S292~S293 (2019)
  21. Azizov M, "Hypoimmune conditions in children with nephrotic syndrome", Acta Paediatrica, International Journal of Paediatrics, 99, pp.103~ (2010)
  22. Chiou YH, "Genetic polymorphisms of CYP3A5 and ABCB1 genes in steroid treatment of children with idiopathic nephrotic syndrome", Pediatric Nephrology, 25, pp.1799~1800 (2010)
  23. Drannik GN, "Assessment of HLA antigens and serum cytokine levels to predict disease progression and treatment responses in children with chronic glomerulonephritis", Journal of Allergy and Clinical Immunology (2016)
  24. Garcia Martinez C, "Mean platelet count as a prognostic biomarker in nephrotic syndrome", Blood Purification, 45, pp.306~ (2018)
  25. Hussein AH, "Evaluation of urinary annexin vas a prognostic marker in children with nephrotic syndrome", Nephrology Dialysis Transplantation, 30, pp.iii147~ (2015)
  26. Jafar T, "MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children", Indian Journal of Clinical Biochemistry, 32, pp.S76~S77 (2017)
  27. Lipkowska K, "The JAK", STAT signaling pathway modifications by glucocorticosteroids in the leukocytes of children with nephrotic syndrome, 2012, pp.27, ii324~
  28. Liu T, "Clinical significance of urine annexin a5 in primary nephrotic syndrome of children", Pediatric Nephrology, 28, pp.1589~ (2013)
  29. Mishra OP, "Toll Like Receptor (TLR) -3, TLR-4 and CD 80 expressions in peripheral blood mononuclear cells and urinary CD 80 levels in children with idiopathic nephrotic syndrome", Pediatric Nephrology, 31, pp.1828~1829 (2016)
  30. Prasad N, "MDR-1 gene polymorphisms in steroid responsive versus steroid resistant nephrotic syndrome in children", Nephrology, 15, pp.99~ (2010)
  31. Prasad N, "Association of MDR-1 gene G2677T", A locus for TT, NDT Plus, pp.2010, 3[DOI]
  32. Sai S, "Reciprocal regulation of 11ß-HSDS may predict steroid sensitivity in childhood nephrotic syndrome", Hormone Research in Paediatrics, 88, pp.250~ (2017)
  33. Sharipov AM, "Immune condition in children with nephrotic syndrome", Intensive Care Medicine, 38, pp.S183~ (2012)
  34. Silska M, "SOCS1 over-expression in peripheral blood lymphocyte may predict resistance to steroids in childhood nephrotic syndrome", Pediatric Nephrology, 25, pp.1883~ (2010)
  35. Singh H, "Expression and function of P-glycoprotein and multidrug resistanceassociated protein-1 and presence of homozygous mutant of multidrug resistance-associated protein-1 single nucleotide polymorphism G2677T", A identify steroid resistance phenotype in childhood idiopathic nephrotic syndrome, 2019, pp.29, S30~S31
  36. Sinha A, "Urinary CD80 (uCD80), serum urokinase type plasminogen activator receptor (suPAR)and serum angiopoietin like 4 (Angptl4) do not distinguish steroid sensitive from steroid resistant nephrotic syndrome (NS)", Pediatric Nephrology, 31, pp.1839~ (2016)
  37. Weissbach A, "High serum TNFalpha level is negatively correlated with steroid responsiveness in primary pediatric nephrotic syndrome", Pediatric Nephrology, 28, pp.1583~ (2013)
  38. Youssef DM, "Soluble interleukine 2 receptor and MDR1 gene expression levels as inflammatory biomarkers for prediction of steroid response in children with nephrotic syndrome", Pediatric Nephrology, 25, pp.1831~ (2010)
  39. Zurbig P, "Peptide biomarker signatures in steroidresistant nephrotic syndrome", Nephrology Dialysis Transplantation, 33, pp.i630~ (2018)
  40. Yang J, "Value of determination of haptoglobin and α1-antitrypsin in predicting response to glucocorticoid therapy in children with primary nephrotic syndrome", Chinese Journal of Contemporary Pediatrics, 17, pp.227~231 (2015)
  41. Zhou TB, "ACE I", D gene polymorphism can't predict the steroid responsiveness in asian children with idiopathic nephrotic syndrome : A meta-analysis, 2011, pp.6, ~
  42. Khurana M, "Urine proteomic profiling of pediatric nephrotic syndrome", Pediatr Nephrol, 21, pp.1257~1265 (2006)
  43. Calişkan S, "Urinary N-acetyl-beta-D-glucosaminidase and beta 2-microglobulin excretion in primary nephrotic children", Nephron, 74, pp.401~404 (1996)
  44. Mishra OP, "Urinary N-acetyl-beta-D glucosaminidase(NAG)level in idiopathic nephrotic syndrome", Pediatr Nephrol, 27, pp.589~596 (2012)
  45. Piyaphanee N, "Discovery and initial validation of α 1-B glycoprotein fragmentation as a differential urinary biomarker in pediatric steroidresistant nephrotic syndrome", Proteomics-Clinical Applications, 5, pp.334~342 (2011)
  46. Suresh CP, "Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome", Clin Exp Nephrol, 20, pp.273~283 (2016)
  47. Mastroianni Kirsztajn G, "Urinary retinol-binding protein as a prognostic marker in the treatment of nephrotic syndrome", Nephron, 86, pp.109~114 (2000)
  48. Simsek B, "Urinary annexin V in children with nephrotic syndrome:A new prognostic marker?", Pediatric Nephrology, 23, pp.79~82 (2008)
  49. Bennett MR, "NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndrome", Pediatric Nephrology, 27, pp.807~812 (2012)
  50. Nickavar A, "Urine Neutrophil Gelatinase Associated Lipocalin to Creatinine Ratio : A Novel Index for Steroid Response in Idiopathic Nephrotic Syndrome", Indian J Pediatr, 83, pp.18~21 (2016)
  51. Bennett MR, "A novel biomarker panel to identify steroid resistance in childhood idiopathic nephrotic syndrome", Biomarker Insights, 12 (2017)
  52. Lee H, "Urinary exosomal WT1 in childhood nephrotic syndrome", Pediatr Nephrol, 27, pp.317~320 (2012)
  53. Mirkovic K, "Urinary vitamin D binding protein : a potential novel marker of renal interstitial inflammation and fibrosis", PLoS One, 8, pp.e55887~ (2013)
  54. Bennett MR, "Urinary vitamin D-binding protein as a biomarker of steroid-resistant nephrotic syndrome", Biomarker Insights, 11, pp.1~6 (2016)
  55. Cengiz N, "Glycosaminoglycan excretion in children with nephrotic syndrome", Pediatric Nephrology, 20, pp.486~490 (2005)
  56. Gopal N, "Assay of urinary protein-bound sialic acid can differentiate steroidsensitive nephrotic syndrome from steroid-resistant cases", Saudi J Kidney Dis Transpl, 27, pp.37~40 (2016)
  57. Shalhoub RJ, "Pathogenesis of lipoid nephrosis : a disorder of T-cell function", Lancet, 2, pp.556~560 (1974)
  58. Mishra OP, "Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome", Pediatric Nephrology, 32, pp.1355~1361 (2017)
  59. Tain YL, "Implications of blood soluble and cell surface tumor necrosis factor receptors in childhood nephrotic syndrome", Pediatric Nephrology, 17, pp.926~932 (2002)
  60. Guan FJ, "Histone deacetylase-2 expression and activity in children with nephrotic syndrome with different glucocorticoid response", Pediatr Nephrol, 33, pp.269~276 (2018)
  61. Youssef DM, "Soluble interleukine-2 receptor and MDR1 gene expression levels as inflammatory biomarkers for prediction of steroid response in children with nephrotic syndrome", Iran J Kidney Dis, 5, pp.154~161 (2011)
  62. Ling C, "Altered B-Lymphocyte homeostasis in Idiopathic Nephrotic Syndrome", Front Pediatr, 7, pp.377~ (2019)
  63. Roy RR, "Serum immunoglobulin G, M and IgG:IgM ratio as predictors for outcome of childhood nephrotic syndrome", World Journal of Pediatrics, 5, pp.127~131 (2009)
  64. Viet TL, "Serum igg level and igg", igm ratio on admission predict steroid-resistant response in vietnamese children with idiopathic nephrotic syndrome, 2019, pp.11, ~
  65. Wei C, "Modification of kidney barrier function by the urokinase receptor", Nat Med, 14, pp.55~63 (2008)
  66. Sever S, "Is there clinical value in measuring suPAR levels in FSGS?", Clin J Am Soc Nephrol, 8, pp.1273~1275 (2013)
  67. Maas RJ, "Serum suPAR in patients with FSGS: trash or treasure?", Pediatr Nephrol, 28, pp.1041~1048 (2013)
  68. Peng Z, "Serum suPAR levels help differentiate steroid resistance from steroid-sensitive nephrotic syndrome in children", Pediatr Nephrol, 30, pp.301~307 (2015)
  69. Mousa SO, "Evaluation of serum soluble urokinase plasminogen activator receptor as a marker for steroid-responsiveness in children with primary nephrotic syndrome", Saudi J Kidney Dis Transpl, 29, pp.290~296 (2018)
  70. Cuzzoni E, "MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome", European Journal of Clinical Pharmacology, 75, pp.1675~1683 (2019)
  71. Watany MM, "Nephronectin(NPNT)and the prediction of nephrotic syndrome response to steroid treatment", European Journal of Human Genetics, 26, pp.1354~1360 (2018)
  72. Ahmed HM, "High Serum Endothelin-1 Level is Associated with Poor Response to Steroid Therapy in Childhood-Onset Nephrotic Syndrome", Saudi J Kidney Dis Transpl, 30, pp.769~774 (2019)
  73. Bakr A, "Oxidant stress in primary nephrotic syndrome: Does it modulate the response to corticosteroids?", Pediatric Nephrology, 24, pp.2375~2380 (2009)
  74. Ochocińska A, "Response to corticosteroid therapy is not related to serum and urine NGAL concentration in nephrotic children", Pediatria Polska, 93, pp.245~250 (2018)
  75. Fodor P, "T-cell dysfunction in minimal-change nephrotic syndrome of childhood", Am J Dis Child, 136, pp.713~717 (1982)
  76. Adalat S, "Efficacy of rituximab in childhood nephrotic syndrome", Pediatric Nephrology, 25, pp.1795~ (2010)
  77. Stachowski J, "Th1", Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome, 2000, pp.14, 779~785
  78. Jaiswal A, "Regulatory and effector T cells changes in remission and resistant state of childhood nephrotic syndrome", Indian J Nephrol, 24, pp.349~355 (2014)
  79. Nakajima H, "Activation of the signal transducer and activator of transcription signaling pathway in renal proximal tubular cells by albumin", J Am Soc Nephrol, 15, pp.276~285 (2004)
  80. Ostalska-Nowicka D, "SOCS3 and SOCS5 mRNA expressions may predict initial steroid response in nephrotic syndrome children", Folia Histochem Cytobiol, 49, pp.719~728 (2011)
  81. Zaorska K, "SOCS3is epigenetically up-regulated in steroid resistant nephrotic children", Acta biochimica Polonica, 63, pp.131~138 (2016)
  82. Hammad A, "Low expression of glucocorticoid receptors in children with steroidresistant nephrotic syndrome", Pediatr Nephrol, 28, pp.759~763 (2013)
  83. Zahran AM, "Glucocorticoid receptors expression and histopathological types in children with nephrotic syndrome", Renal Failure, 36, pp.1067~1072 (2014)
  84. Reiser J, "Induction of B7-1 in podocytes is associated with nephrotic syndrome", J Clin Invest, 113, pp.1390~1397 (2004)
  85. Ji LD, "Association of angiotensinogen gene M235T and angiotensin-converting enzyme gene I", D polymorphisms with essential hypertension in Han Chinese population : a meta-analysis, 2010, pp.28, 419~428
  86. Qin YH, "Association between ACE polymorphism and risk of IgA nephropathy : a meta-analysis", J Renin Angiotensin Aldosterone Syst, 12, pp.215~223 (2011)
  87. Schena FP, "ACE gene polymorphism and IgA nephropathy : an ethnically homogeneous study and a meta-analysis", Kidney Int, 60, pp.732~740 (2001)
  88. Al-Eisa A, "Angiotensin converting enzyme gene insertion", deletion polymorphism in idiopathic nephrotic syndrome in Kuwaiti Arab children, 2001, pp.35, 239~242
  89. Celik US, "ACE gene polymorphism in Turkish children with nephrotic syndrome", Ren Fail, 28, pp.401~403 (2006)
  90. Prasun P, "Association of angiotensin-converting enzyme gene I", D polymorphism with steroid responsiveness in childhood nephrotic syndrome, 2011, pp.21, 26~29
  91. Sasse B, "Angiotensin converting enzyme gene polymorphisms do not predict the course of idiopathic nephrotic syndrome in Swiss children", Nephrology, 11, pp.538~541 (2006)
  92. Serdaroglu E, "ACE gene insertion", deletion polymorphism in childhood idiopathic nephrotic syndrome, 2005, pp.20, 1738~1743
  93. Tsai IJ, "Angiotensinconverting enzyme gene polymorphism in children with idiopathic nephrotic syndrome", Am J Nephrol, 26, pp.157~162 (2006)
  94. Batinic D, "Angiotensin-converting enzyme genotype is not a significant genetic risk factor for idiopathic nephrotic syndrome in Croatian children", Nephron, 130, pp.29~34 (2015)
  95. Tabel Y, "Effects of genetic polymorphisms of the renin-angiotensin system in children with nephrotic syndrome", J Renin Angiotensin Aldosterone Syst, 6, pp.138~144 (2005)
  96. Abdel-Hafez M, "Idiopathic Nephrotic Syndrome and Atopy: Is There a Common Link?", American Journal of Kidney Diseases, 54, pp.945~953 (2009)
  97. Daehn I, "Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis", J Clin Invest, 124, pp.1608~1621 (2014)
  98. Ezzat GM, "Association of endothelin receptor type A rs5333 gene polymorphism with steroid response in Egyptian children with idiopathic nephrotic syndrome", Pharmacogenomics, 20, pp.133~141 (2019)
  99. Attila G, "Apolipoprotein E polymorphism in childhood nephrotic syndrome", Pediatr Nephrol, 17, pp.359~362 (2002)
  100. Ye J, "Genetic variations of the NR3C1 gene in children with sporadic nephrotic syndrome", Biochem Biophys Res Commun, 348, pp.507~513 (2006)
  101. Cheong HI, "GLCCI1 single nucleotide polymorphisms in pediatric nephrotic syndrome", Pediatr Nephrol, 27, pp.1595~1599 (2012)
  102. Choi HJ, "Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome", Pediatr Nephrol, 26, pp.1981~1988 (2011)
  103. Jafar T, "MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children", Nephrol Dial Transplant, 26, pp.3968~3974 (2011)
  104. Kara A, "Evaluation of Genetic Polymorphisms for Determining Steroid Response in Nephrotic Children", Ann Clin Lab Sci, 48, pp.478~483 (2018)
  105. Moussa A, "MDR-1 and CYP3A5 polymorphisms in pediatric idiopathic nephrotic syndrome : Impact on susceptibility and response to steroids(Preliminary Results)", Clinical Laboratory, 63, pp.1233~1242 (2017)
  106. Youssef DM, "Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome : impact on susceptibility and response to steroids", Gene, 530, pp.201~207 (2013)
  107. Berdeli A, "Association of macrophage migration inhibitory factor-173C allele poly morphism with steroid resistance in children with nephrotic syndrome", Pediatr Nephrol, 20, pp.1566~1571 (2005)
  108. Vivarelli M, "Association of the macrophage migration inhibitory factor-173*C allele with childhood nephrotic syndrome", Pediatr Nephrol, 23, pp.743~748 (2008)
  109. Ramayani OR, "A genetic study of steroid-resistant nephrotic syndrome : relationship between polymorphism-173 G to C in the MIF gene and serum level MIF in children", J Dev Orig Health Dis, 7, pp.102~107 (2016)
  110. Świerczewska M, "Polymorphic variants of MIF gene and prognosis in steroid therapy in children with idiopathic nephrotic syndrome", Acta Biochim Pol, 61, pp.67~75 (2014)
  111. Chiou YH, "Genetic polymorphisms influence the steroid treatment of children with idiopathic nephrotic syndrome", Pediatr Nephrol, 27, pp.1511~1517 (2012)
  112. Turolo S, "SXR rs3842689 : A prognostic factor for steroid sensitivity or resistance in pediatric idiopathic nephrotic syndrome", Pharmacogenomics, 17, pp.1227~1233 (2016)
  113. Jafar T, "Cytokine gene polymorphism in idiopathic nephrotic syndrome children", Indian J Clin Biochem, 26, pp.296~302 (2011)
  114. Midan DAR, "Cytokine Gene Polymorphism in Children With Idiopathic Nephrotic Syndrome", Iran J Kidney Dis, 11, pp.414~421 (2017)
  115. Youssef DM, "Tumor necrosis factor alpha gene polymorphisms and haplotypes in Egyptian children with nephrotic syndrome", Cytokine, 102, pp.76~82 (2018)
  116. Caridi G, "Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis", J Am Soc Nephrol, 12, pp.2742~2746 (2001)
  117. Ruf RG, "Patients with mutations in NPHS2(podocin)do not respond to standard steroid treatment of nephrotic syndrome", J Am Soc Nephrol, 15, pp.722~732 (2004)
  118. Caridi G, "Broadening the spectrum of diseases related to podocin mutations", J Am Soc Nephrol, 14, pp.1278~1286 (2003)
  119. Tsukaguchi H, "NPHS2 mutations in late-onset focal segmental glomerulosclerosis : R229Q is a common disease-associated allele", J Clin Invest, 110, pp.1659~1666 (2002)
  120. Franceschini N, "NPHS2gene, nephrotic syndrome and focal segmental glomerulosclerosis:a HuGE review", Genet Med, 8, pp.63~75 (2006)
  121. Lu L, "The p.R229Q variant of the NPHS2 (podocin) gene in focal segmental glomerulosclerosis and steroid-resistant nephrotic syndrome: a meta-analysis", Int Urol Nephrol, 46, pp.1383~1393 (2014)
  122. Ali SH, "R229Q Polymorphism of NPHS2 Gene in Group of Iraqi Children with Steroid-Resistant Nephrotic Syndrome", Int J Nephrol, 2017, pp.1407506~ (2017)
  123. Gbadegesin R, "Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome", Pediatr Nephrol, 22, pp.509~513 (2007)
  124. Zaki M, "Analysis of NPHS2 Gene Mutations in Egyptian Children with Nephrotic Syndrome", Open Access Maced J Med Sci, 7, pp.3145~3148 (2019)
  125. Winn MP, "A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis", Science, 308, pp.1801~1804 (2005)
  126. Kuang XY, "254C>G : a TRPC6 promoter variation associated with enhanced transcription and steroid-resistant nephrotic syndrome in Chinese children", Pediatr Res, 74, pp.511~516 (2013)
  127. Gulati S, "Is typing for HLA class II alleles beneficial in Indian children with idiopathic nephrotic syndrome?", Pediatric Nephrology, 22, pp.528~532 (2007)
  128. Ramanathan AS, "Association of HLA-DR", DQ alleles and haplotypes with nephrotic syndrome, 2016, pp.21, 745~752
  129. Schwarz R, "The prognosis of idiopathic nephrotic syndrome : a comparative study between the index of selectivity of proteinuria and the findings in renal biopsies", Padiatrie und Padologie, 15, pp.131~136 (1980)
  130. Lagrue G, "Proteinuria selectivity index : prognostic value in idiopathic nephrotic syndromes", Annales de médecine interne, 142, pp.249~253 (1991)
  131. Zaki M, "Proteinuria selectivity in childhood nephrotic syndrome", Bahrain Medical Bulletin, 19, pp.15~17 (1997)
  132. Choudhary A, "Association of urinary Vitamin-D binding protein and neutrophil gelatinase-associated lipocalin with steroid responsiveness in idiopathic nephrotic syndrome of childhood", Indian Journal of Clinical Biochemistry, 33, pp.S90~ (2018)
  133. Kaneko K, "Th1", Th2 balance in childhood idiopathic nephrotic syndrome, 2002, pp.58, 393~397
  134. Stachowski J, "Th1", Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome, 2000, pp.14, 779~785
  135. Yap HK, "Th1and Th2 cytokine mRNA profiles in childhood nephrotic syndrome : evidence for increased IL-13 mRNA expression in relapse", J Am Soc Nephrol, 10, pp.529~537 (1999)
  136. Bustos C, "Increase of tumour necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome", Eur J Clin Invest, 24, pp.799~805 (1994)
  137. Agrawal S, "Predicting and Defining Steroid Resistance in Pediatric Nephrotic Syndrome Using Plasma Proteomics", Kidney International Reports, 5, pp.66~80 (2020)
  138. Gooding JR, "Predicting and Defining Steroid Resistance in Pediatric Nephrotic Syndrome Using Plasma Metabolomics", Kidney Int Rep, 5, pp.81~93 (2020)
  139. Han SS, "A PRISMA-compliant metaanalysis of MDR1 polymorphisms and idiopathic nephrotic syndrome:Susceptibility and steroid responsiveness", Medicine (Baltimore), 96, pp.e7191~ (2017)
  140. Wang L, "The role of Th17", IL-17 in the pathogenesis of primary nephrotic syndrome in children, 2013, pp.37, 332~345
  141. Kang HG, "Markers of disease and steroid responsiveness in paediatric idiopathic nephrotic syndrome : Whole-transcriptome sequencing of peripheral blood mononuclear cells", J Int Med Res, 45, pp.948~963 (2017)
  142. Xing CY, "Direct effects of dexamethasone on human podocytes", Kidney Int, 70, pp.1038~1045 (2006)
  143. Zachwieja J, "Intracellular cytokines of peripheral blood lymphocytes in nephrotic syndrome", Pediatr Nephrol, 17, pp.733~740 (2002)
  144. Zhou TB, "Insertion", deletion(I, Ren Fail, pp.2011, 33[DOI]

관련 논문AI추천

이 간행물의 다른 논문 (8건)